@article{4e9f7792a5e44f6d87d7f46ea542a6f7,
title = "Editorial: Facing the Upcoming of Multidrug-Resistant and Extensively Drug-Resistant Bacteria: Novel Antimicrobial Therapies (NATs)",
keywords = "antibiotic resistance, antimicrobial peptides, antimicrobial therapies, combinatorial treatments, extensively drug-resistant bacteria, metal nanoparticles, multidrug-resistant bacteria",
author = "Angel Le{\'o}n-Buitimea and Morones-Ram{\'i}rez, {Jose Ruben} and Yang, {Jason H.} and Rafael Pe{\~n}a-Miller",
note = "Funding Information: This work was supported by funding from the National Institutes of Health, grant R00GM118907 to JY, the Universidad Aut{\'o}noma de Nuevo Le{\'o}n (Paicyt 2016-2017, Paicyt 2019-2020, and Paicyt 2020-2021), and CONACyT Science Grants (Basic Science grant 221332, Fronteras de la Ciencia grant 1502, and Infraestructura Grant 279957) to JM-R. AL-B was supported by Beca de Posdoctorado Nacional 2018-2020.",
year = "2021",
month = feb,
day = "23",
doi = "10.3389/fbioe.2021.636278",
language = "English (US)",
volume = "9",
journal = "Frontiers in Bioengineering and Biotechnology",
issn = "2296-4185",
publisher = "Frontiers Media SA",
}